Adenovirus vector delivery stimulates natural killer cell recognition

Journal of General Virology

Volumn 88, Issue 4, 2007, Pages 1103-1108

  Tomasec, Peter ^a   Wang, Eddie C Y ^a   Groh, Veronika ^b   Spies, Thomas ^b   McSharry, Brian P ^a   Aicheler, Rebecca J ^a   Stanton, Richard J ^a   Wilkinson, Gavin W G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; NATURAL KILLER CELL RECEPTOR NKG2D;

ARTICLE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; FIBROBLAST; GAMMA IRRADIATION; GENE EXPRESSION REGULATION; HLA MATCHING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FIBROBLASTS; GENETIC VECTORS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC;

ADENOVIRIDAE;

EID: 34047135584     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82685-0     Document Type: Article

References (44)

1. Aldemir, H., Prod'homme, V., Dumaurier, M. J., Retiere, C., Poupon, G., Cazareth, J., Bihl, F. & Braud, V. M. (2005). Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 175, 7791-7795.
2. Bacon, L., Eagle, R. A., Meyer, M., Easom, N., Young, N. T. & Trowsdale, J. (2004). Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol 173, 1078-1084.
3. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. & Spies, T. (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729.
4. Borgland, S. L., Bowen, G. P., Wong, N. C., Libermann, T. A. & Muruve, D. A. (2000). Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J Virol 74, 3941-3947.
5. Bottino, C., Castriconi, R., Pende D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S. & other authors (2003). Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198, 557-567.
6. Chalupny, N. J., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A. & Cosman, D. (2003). ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305, 129-135.
7. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. & Hsu, M. L. (1997). A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273-282.
8. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. & Chalupny, N. J. (2001). ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133.
9. Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C. S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T. & Danel, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 8, 42-51.
10. Dunn, C., Chalupny, N. J., Sutherland, C. L., Dosch, S., Sivakumar, P. V., Johnson, D. C. & Cosman, D. (2003). Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197, 1427-1439.
11. Fooks, A. R., Schadeck, E., Liebert, U. G., Dowsett, A. B., Rima, B. K., Steward, M., Stephenson, J. R. & Wilkinson, G. W. (1995). High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210, 456-465.
12. Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Buhring, H. J., Dichgans, J., Rammensee, H. G. & other authors (2003). MICA/NKG2D-mediated immunogene therapy of experimental gliomas. Cancer Res 63, 8996-9006.
13. Fuchs, A., Cella, M., Giurisato, E., Shaw, A. S. & Colonna, M. (2004). Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol 172, 3994-3998.
14. Gasser, S., Orsulic, S., Brown, E. J. & Raulet D. H. (2005). The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190.
15. Griffin, C., Wang, E. C., McSharry, B. P., Rickards, C., Browne, H., Wilkinson, G. W. & Tomasec, P. (2005). Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J Gen Virol 86, 2999-3008.
16. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M. & Spies, T. (1996). Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 93, 12445-12450.
17. Groh, V., Steinle, A., Bauer, S. & Spies, T. (1998). Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279, 1737-1740.
18. Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R. & Spies, T. (2001). Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2, 255-260.
19. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W. & Vogelstein, B. (1998). A simplified system for generating recombinant adeno-viruses. Proc Natl Acad Sci U S A 95, 2509-2514.
20. Lanier, L. L. (2005). NK cell recognition. Annu Rev Immunol 23, 225-274.
21. Li, E., Stupack, D., Klemke, R., Cheresh, D. A. & Nemerow, G. R. (1998). Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol 72, 2055-2061.
22. Liu, O. & Muruve, D. A. (2003). Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 10, 935-940.
23. Marshall, E. (1999). Gene therapy death prompts review of adenovirus vector. Science 286, 2244-2245.
24. McGrory, W. J., Bautista, D. S. & Graham, F. L. (1988). A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617.
25. McSharry, B. P., Jones, C. J., Skinner, J. W., Kipling, D. & Wilkinson, G. W. (2001). Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus. J Gen Virol 82, 855-863.
26. Morris, R. J., Chong, L. K., Wilkinson, G. W. & Wang, E. C. (2005). A high-efficiency system of natural killer cell cloning. J Immunol Methods 307, 24-33.
27. Muruve, D. A. (2004). The innate immune response to adenovirus vectors. Hum Gene Ther 15, 1157-1166.
28. Muruve, D. A., Cotter, M. J., Zeiss, A. K., White, L. R., Liu, O., Chan, T., Clark, S. A., Ross, P. J., Meulenbroek, R. A. & other authors (2004). Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J Virol 78, 5966-5972.
29. Nakajima, H., Cella, M., Langen, H., Friedlein, A. & Colonna, M. (1999). Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 29, 1676-1683.
30. Philpott, N. J., Nociari, M., Elkon, K. B. & Falck-Pedersen, E. (2004). Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway. Proc Natl Acad Sci U S A 101, 6200-6205.
31. Rafii, S., Dias, S., Meeus, S., Hattori, K., Ramachandran, R., Feuerback, F., Worgall, S., Hackett, N. R. & Crystal, R. G. (2001). Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression. Circ Res 88, 903-910.
32. Raper, S. E., Chirmule, N., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G. P., Wilson, J. M. & Batshaw, M. L. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80, 148-158.
33. Robertson, M. J., Cochran, K. J., Cameron, C., Le, J. M., Tantravahi, R. & Ritz, J. (1996). Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24, 406-415.
34. Rosen, D. B., Bettadapura, J., Alsharifi, M., Mathew, P. A., Warren, H. S. & Lanier, L. L. (2005). Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol 175, 7796-7799.
35. Routes, J. M., Ryan, S., Morris, K., Takaki, R., Cerwenka, A. & Lanier, L. L. (2005). Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. J Exp Med 202, 1477-1482.
36. Ruzek, M. C., Kavanagh, B. F., Scaria, A., Richards, S. M. & Garman, R. D. (2002). Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression. Mol Ther 5, 115-124.
37. Schnell, M. A., Zhang, Y., Tazelaar, J., Gao, G. P., Yu, O. C., Qian, R., Chen, S. J., Varnavski, A. N., LeClair, C. & other authors (2001). Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 3, 708-722.
38. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J. & Wilkinson, G. W. (2000). Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031.
39. Tomasec, P., Wang, E. C., Davison, A. J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B. P., Morris, R. J., Llewellyn-Lacey, S. & other authors (2005). Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6, 181-188.
40. Welte, S. A., Sinzger, C., Lutz, S. Z., Singh-Jasuja, H., Sampaio, K. L., Eknigk, U., Rammensee, H. G. & Steinle, A. (2003). Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33, 194-203.
41. Wilkinson, G. W. & Akrigg, A. (1992). Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20, 2233-2239.
42. Wills, M. R., Carmichael, A. J., Maynard, K., Xin, J., Weekes, M. P., Plachter, B. & Sissons, J. G. (1996). The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity and T-cell receptor usage of pp65-specific CTL. J Virol 70, 7569-7579.
43. Wills, M. R., Ashiru, O., Reeves, M. B., Okecha, G., Trowsdale, J., Tomasec, P., Wilkinson, G. W., Sinclair, J. & Sissons, J. G. (2005). Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175, 7457-7465.
44. Xu, X., Zhang, H. G., Liu, Z. Y., Wu, Q., Yang, P. A., Sun, S. H., Chen, J., Hsu, H. C. & Mountz, J. D. (2004). Defective clearance of adenovirus in IRF-1 mice associated with defects in NK and T cells but not macrophages. Scand J Immunol 60, 89-99.